Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
NeuroPace ( (NPCE) ) just unveiled an update.
NeuroPace is set to present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025, showcasing their latest advancements in neurological medical devices. The presentation will be accessible via a live audio webcast, potentially enhancing the company’s visibility and stakeholder engagement.
More about NeuroPace
NeuroPace, Inc. operates in the healthcare industry, primarily focusing on medical devices designed for neurological applications.
YTD Price Performance: 2.25%
Average Trading Volume: 88,595
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $353.4M
For an in-depth examination of NPCE stock, go to TipRanks’ Stock Analysis page.
